Literature DB >> 29478603

Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis.

Stephen A Goutman1, Kevin S Chen2, Ximena Paez-Colasante3, Eva L Feldman3.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive, noncurable neurodegenerative disorder of the upper and lower motor neurons causing weakness and death within a few years of symptom onset. About 10% of patients with ALS have a family history of the disease; however, ALS-associated genetic mutations are also found in sporadic cases. There are over 100 ALS-associated mutations, and importantly, several genetic mutations, including C9ORF72, SOD1, and TARDBP, have led to mechanistic insight into this complex disease. In the clinical realm, knowledge of ALS genetics can also help explain phenotypic heterogeneity, aid in genetic counseling, and in the future may help direct treatment efforts.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  amyotrophic lateral sclerosis; amyotrophic lateral sclerosis gene therapy; amyotrophic lateral sclerosis genetic counseling; amyotrophic lateral sclerosis genetics; amyotrophic lateral sclerosis pathophysiology; amyotrophic lateral sclerosis phenotypes

Mesh:

Substances:

Year:  2018        PMID: 29478603     DOI: 10.1016/B978-0-444-64076-5.00039-9

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  11 in total

Review 1.  Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials.

Authors:  Stephen A Goutman; Masha G Savelieff; Stacey A Sakowski; Eva L Feldman
Journal:  Expert Opin Investig Drugs       Date:  2019-06-12       Impact factor: 6.206

Review 2.  Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis.

Authors:  Stephen A Goutman; Orla Hardiman; Ammar Al-Chalabi; Adriano Chió; Masha G Savelieff; Matthew C Kiernan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2022-03-22       Impact factor: 59.935

Review 3.  Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.

Authors:  Stephen A Goutman; Orla Hardiman; Ammar Al-Chalabi; Adriano Chió; Masha G Savelieff; Matthew C Kiernan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2022-03-22       Impact factor: 59.935

4.  Quantitative proteomic analyses of CD4+ and CD8+ T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls.

Authors:  Tone Berge; Anna Eriksson; Ina Skaara Brorson; Einar August Høgestøl; Pål Berg-Hansen; Anne Døskeland; Olav Mjaavatten; Steffan Daniel Bos; Hanne F Harbo; Frode Berven
Journal:  Clin Proteomics       Date:  2019-05-08       Impact factor: 3.988

Review 5.  A Systematic Review of Genotype-Phenotype Correlation across Cohorts Having Causal Mutations of Different Genes in ALS.

Authors:  Owen Connolly; Laura Le Gall; Gavin McCluskey; Colette G Donaghy; William J Duddy; Stephanie Duguez
Journal:  J Pers Med       Date:  2020-06-29

Review 6.  Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Authors:  Mehdi Ghasemi; Kiandokht Keyhanian; Catherine Douthwright
Journal:  Cells       Date:  2021-01-28       Impact factor: 6.600

Review 7.  Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Santiago E Charif; M Florencia Vassallu; Lara Salvañal; Lionel M Igaz
Journal:  Neural Regen Res       Date:  2022-07       Impact factor: 5.135

8.  Dysregulated biodynamics in metabolic attractor systems precede the emergence of amyotrophic lateral sclerosis.

Authors:  Paul Curtin; Christine Austin; Austen Curtin; Chris Gennings; Claudia Figueroa-Romero; Kristen A Mikhail; Tatiana M Botero; Stephen A Goutman; Eva L Feldman; Manish Arora
Journal:  PLoS Comput Biol       Date:  2020-04-15       Impact factor: 4.475

9.  A retrospective study of the clinical phenotype and predictors of survival in non-Caucasian Hispanic patients with amyotrophic lateral sclerosis.

Authors:  Claudia Marisol Sánchez-Martínez; José Alberto Choreño-Parra; Lilia Nuñez-Orozco; Noel Placencia-Álvarez; Laura Marcela Alvis-Castaño; Parménides Guadarrama-Ortiz
Journal:  BMC Neurol       Date:  2019-10-29       Impact factor: 2.474

10.  Untargeted metabolomics yields insight into ALS disease mechanisms.

Authors:  Stephen A Goutman; Jonathan Boss; Kai Guo; Fadhl M Alakwaa; Adam Patterson; Sehee Kim; Masha Georges Savelieff; Junguk Hur; Eva L Feldman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-09-14       Impact factor: 13.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.